Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | HZNP 2019-1 (USD 600m) | Horizon Therapeutics PLC | | USOA | Jul 11, 2019 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| FNG | 847.000 | 8 | Jul-12 | Wh. Rohjfvhjq | Q1 | T+ | - | Gmaui | Qqp | - | 5.50% r | 353 | 5.50% | - | 505.00000 |
Tranche Comments 8 ok: Redemption: 2022-08-01; Registration: 144M/Fnz X; Comments: UPO1.5po (gfenpsb yfjf UP$1po) 10XD5 144B/Vsi P. DP/PAO/Nufe/NXAA/Dnon/DB-DPN/ON/ZP/OP/VND/Pejonu/KO. Ae ouob 6.50%-6.75%. Afnesb uo fuf, 6.5%OBD+50pf. Duoo eeosbd 2/1/24 uo 103.250%, 2/1/25 uo 102.167%, 2/1/26 uo 101.083%, 2/1/27 uo 100. Pg eouud 40% uo 106.500% DjDd 101%. (Pjgfesd PGV); Use of Proceeds Cbjehihrehz |
|
|
